Spartanburg, SC – April 22, 2011 – QS/1 is helping Kansas pharmacies report sales of cold and allergy medications to the state. Beginning April 29, 2011, Kansas pharmacies that sell medications containing ephedrine, pseudoephedrine, and/or phenylpropanolamine products must comply with a new law that requires real-time PSE reporting to the state. This electronic monitoring program helps officials in the state of Kansas track illegal PSE purchases.

The QS/1 Point-of-Sale system records PSE sales and can create a report to be sent to the state agency responsible for tracking the data. This feature means Kansas pharmacies can be compliant with the state law without having to manually log the information and send it to the agency.

Pharmacies in Kansas or other states that require a similar PSE report should contact QS/1 Healthcare Services at 800.845.7558 extension 1471 more for information.

QS/1, a complete healthcare automation solution provider, serves both pharmacies and HME businesses. QS/1 is a division of the J M Smith Corporation, the third largest privately held company in South Carolina. For additional information about QS/1, visit the website at www.qs1.com, or call 800.231.7776.